DANIELA ROMERO: Open Payments
NPI 1699499921 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 45 payments from 10 companies in 2025. Trend: 2023 $1,609 · 2024 $2,072 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $789 |
| JAZZ PHARMACEUTICALS INC. | 9 | $347 |
| ABBVIE INC. | 8 | $202 |
| LivaNova USA, Inc. | 1 | $109 |
| SK Life Science, Inc. | 3 | $85 |
| Neurelis, Inc. | 3 | $74 |
| PFIZER INC. | 2 | $46 |
| Lundbeck LLC | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: EPIDIOLEX, Fintepla, Briviact, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, QULIPTA, VALTOCO, Nayzilam, UBRELVY.
Industry payments across FL — which companies pay providers there.
